Additionally, the pan-BCL2 inhibitor, obatoclax, which inhibits BCL2, BCL-xL, and MCL1, induces apoptotic cell death in DLBCL cell lines including MCL1 positive ones (43, 122). Here, BCL2 is linked to diffuse large B-cell lymphoma.